Table 2.
Baseline Characteristics.
| Characteristic | Intervention (N = 150) | Usual Care (N = 150) |
|---|---|---|
| Age – year median (iqr) | 71 (64–78) | 73 (65–79) |
| Female sex - NO (%) | 2 (0.01%) | 2 (0.01%) |
| Race - NO (%) | ||
| Black or african american | 49 (38%) | 43 (33%) |
| White | 74 (57%) | 82 (63%) |
| Asian | 5 (4%) | 2 (1%) |
| Native hawaiian or other pacific islander | 2 (2%) | 2 (2%) |
| American indian or alaska native usual care | 0 (0%) | 1 (1%) |
| 3 month (3 M) hospitalization rank* | 92 (83–97) | 91 (81–97) |
| >1 HF admissions (VA-1Y) (%)** | 4.7% | 4.7% |
| Optimization potential score - NO (%) | ||
| 0 | 19 (13%) | 18 (12%) |
| 1 | 22 (15%) | 24 (16%) |
| 2 | 38 (25%) | 36 (24%) |
| 3 | 31 (21%) | 32 (21%) |
| 4 | 22 (15%) | 21 (14%) |
| 5 | 18 (12%) | 19 (13%) |
| GDMT prescribed – No (%) | ||
| ACE/ARB/ARNI | 102 (68%) | 99 (66%) |
| Beta blocker | 118 (79%) | 120 (80%) |
| MRA | 44 (29%) | 44 (29%) |
| SGLT-2i | 16 (11%) | 17 (11%) |
| GDMT target dose achieved – NO (%) | ||
| ACE/ARB/ARNI | 15 (10%) | 15 (10%) |
| BETA BLOCKER | 15 (10%) | 18 (12%) |
| MRA | 16 (11%) | 14 (9%) |
| SGLT-2i | 16 (11%) | 17 (11%) |
| Systolic blood pressure (mm Hg, 1Y)† | 125 (111–134) | 119 (107–135) |
| Diastolic blood pressure (mm Hg, 1Y)† | 69 (59–77) | 69 (58–79) |
| Pulse (beats per minute, 1Y)† | 75 (66–85) | 74 (67–85) |
| Weight (pounds, 3Y)† | 187 (158–222) | 188 (157–225) |